Home » Topics » BioWorld Science

BioWorld Science
RSS

New lysosomal acid glucosylceramidase inhibitors identified at Takeda

Aug. 27, 2019

Esteve Pharmaceuticals describes dual CACNA2D1/mu opioid receptor ligands

Aug. 27, 2019

IL-2-R336A fusion toxin enhances antitumor immune response in preclinical models

Aug. 27, 2019

PACAP27 identified as a novel target for the treatment of migraine

Aug. 27, 2019

Positive topline results from pivotal phase III ORION-11 study of inclisiran

Aug. 27, 2019

FDA grants approval for Taltz as treatment of active ankylosing spondylitis

Aug. 27, 2019

New potent vanin-1 inhibitor as preclinical candidate for inflammatory bowel disease

Aug. 27, 2019

Tuberculosis vaccine MTBVAC shows promise in phase I/II trial in adults and infants

Aug. 27, 2019

CD40-targeting peptide KGYY-6 may ameliorate multiple sclerosis

Aug. 27, 2019

Chromatin problem linked to accelerated aging

Aug. 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.